Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages

  Wright, Karen D ^a   Onciu, Mihaela M ^a   Coustan Smith, Elaine ^a   Campana, Dario ^a   Raimondi, Susana C ^a   Inaba, Hiroto ^a   Ribeiro, Raul ^a   Pui, Ching Hon ^a   Sandlund, John T ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

CD4; CD56; Dendritic cell; Hematodermic tumors; Leukemia

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL DIFFERENTIATION; CEREBROSPINAL FLUID ANALYSIS; CHILD; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HUMAN; IN SITU HYBRIDIZATION; INGUINAL LYMPH NODE; LEUKEMIA CELL; LEUKOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE TUMOR; THROMBOCYTE COUNT; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; HUMANS; LEUKEMIA; MALE;

EID: 84878258277     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24483     Document Type: Article

References (20)

1. + malignancies. Blood 2002;99:1556-1563.
2. Petrella T, Bagot M, Willemze R, et al. Blastic NK- cell lymphomas (agranular CD4+ CD56+ hematodermic neoplasms): A review. Am J Clin Pathol 2005;123:662-675.
3. Reimer P, Rudiger T, Kraemer D, et al. What is CD4+ CD56+ malignancy and how should it be treated? Bone Marrow Transplant 2003;32:637-646.
4. Anargyrou K, Paterakis, G, Boutsis D, et al. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol 2003;71:294-298.
5. Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: Diagnostic features and clinical implications. Haematologica 2010;95:1873-1879.
6. Reineks EZ, Osei ES, Rosenberg A, et al. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometry 2009;76:237-248.
7. Rossi JG, Felice MS, Bernasconi AR, et al. Acute leukemia of dendritic cell lineage in childhood: Incidence, biological characteristics and outcome. Leuk Lymphoma 2006;47:715-725.
8. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009;360:2730-2741.
9. Pilichowska ME, Fleming MD, Pinkus JL, et al. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol 2007;128:445-453.
10. Hama A, Kudo K, Itzel BV, et al. Plasmacytoid dendritic cell leukemia in children. J Pediatr Hematol Oncol 2009;31:339-343.
11. Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues, 4th edition. Lyon: The International Agency for Research on Cancer (IARC) Press; 2008.
12. Wagner G, Fenchel K, Back W, et al. Leukemia cutis-Epidemiology, clinical presentation, and differential diagnoses. J Dtsch Dermatol Ges 2012;10:27-36.
13. Ratnam KV, Khor CJ, Su WP. Leukemia cutis. Dermatol Clin 1994;12:419-431.
14. Kaddu S, Zenahlik P, Beham-Schmid C, et al. Specific cutaneous infiltrates in patients with myelogenous leukemia: A clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol 1999;40:966-978.
15. Cronin DM, George TI, Reichard KK, et al. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm. Am J Clin Pathol 2012;137:367-376.
16. Eguaras AV, Lo RW, Veloso JD, et al. CD4+/CD56+ hematodermic neoplasm: Blastic NK cell lymphoma in a 6-year-old child: Report of a case and review of literature. J Pediatr Hematol Oncol 2007;29:766-769.
17. Ruggiero A, Maurizi P, Larocca LM, et al. Childhood CD4+/CD56+ hematodermic neoplasm: Case report and review of the literature. Haematologica 2006;91:48.
18. Falcao RP, Garcia AB, Marques MG, et al. Blastic CD4 NK cell leukemia/lymphoma: A distinct clinical entity. Leuk Res 2002;26:803-807.
19. Petrella T, Comeau MR, Maynadie M, et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26:852-862.
20. Dijkman R, van Doorn R, Szuhai K, et al. Gene-expression profiling and array-based CGH classify CD4+ CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 2007;109:1720-1727.